Authors Dr. Lynne Eldridge and David Tabatsky to speak at LUNGevity's Fourth Annual Lung Cancer Survivorship Summit

WASHINGTON, March 14, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation is inviting lung cancer patients/survivors from across the nation to register for the fourth annual national LUNGevity HOPE Summit to be held on May 2- 4, 2014, at the Key Bridge Marriott in Arlington, VA. The two-day meeting, kicking off Lung Cancer Hope Month, is designed for people living with lung cancer of all ages and stages of the disease, currently in or out of treatment.

LUNGevity HOPE Summits provide an opportunity for participants to celebrate lung cancer survivorship while they learn, collaborate, advocate, and use their voices and stories to make a difference in the fight against lung cancer. The May summit will offer inspirational speakers (including authors Lynne Eldridge, MD, and David Tabatsky), medical expert forums, and lung cancer survivor-specific sessions, with sessions specifically for people in active treatment and others for those out of treatment. Perhaps most important, there will be opportunities for people living with lung cancer to share and connect with other patients/survivors to build a lasting community.

To learn more about the 2014 HOPE Summit and to register, visit www.LUNGevity.org/HOPESUMMIT.  All conference sessions, meals, speakers, materials, and access to exhibits during the summit will be provided to registrants at no cost beyond the $50 application fee. A limited number of travel grants are available for transportation to Washington, DC, and two-night hotel accommodations at the Key Bridge Marriott.

For more detailed information, please email [email protected] with any questions about this summit or about the 2014 regional summits coming up in Columbus, OH, and Seattle, WA, later this year.

About LUNGevity Foundation

LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as by providing community, support, and education for all those affected by the disease. Our vision is a world where no one dies of lung cancer. For more information about LUNGevity Foundation, please visit www.LUNGevity.org.

Since 2002, LUNGevity has funded 100 research projects at 56 institutions in 23 states and has connected people to lung cancer survivorship through research, education, and support. Throughout the year, LUNGevity coordinates grassroots and large-scale initiatives with the goal of funding research in order to extend patients' lives and improve quality of life post-diagnosis. The research is specifically focused on expediting development of an effective early-detection strategy and identifying therapeutic agents that provide customized genetic intervention for lung cancer.

About Lung Cancer

• Lung cancer is currently the leading cause of cancer death, affecting one in 14 Americans.
• Anyone can develop lung cancer – 60% of diagnoses are in people who have never smoked or quit years earlier.
• Twice as many women die from lung cancer as do from breast cancer and three times as many men die from lung cancer as compared with prostate cancer.
• If caught early, the survival rate at five years is more than triple what it would otherwise be.

SOURCE LUNGevity Foundation